Lapatinib Completed Phase 1 Trials for Malignancies / Renal Cell Adenocarcinoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT00516672Phase I Study of Pazopanib Alone and In Combination With Lapatinib in Japanese Patients With Solid Tumors
NCT00158782Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients